These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20869439)

  • 1. Human serum binding and its effect on the pharmacodynamics of the lantibiotic MU1140.
    Ghobrial O; Derendorf H; Hillman JD
    Eur J Pharm Sci; 2010 Dec; 41(5):658-64. PubMed ID: 20869439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic evaluation of the lantibiotic MU1140.
    Ghobrial O; Derendorf H; Hillman JD
    J Pharm Sci; 2010 May; 99(5):2521-8. PubMed ID: 20039385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic activity of the lantibiotic MU1140.
    Ghobrial OG; Derendorf H; Hillman JD
    Int J Antimicrob Agents; 2009 Jan; 33(1):70-4. PubMed ID: 18835136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureus.
    Tsuji BT; Yang JC; Forrest A; Kelchlin PA; Smith PF
    J Antimicrob Chemother; 2008 Jul; 62(1):156-60. PubMed ID: 18400804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.
    Begic D; von Eiff C; Tsuji BT
    J Antimicrob Chemother; 2009 May; 63(5):977-81. PubMed ID: 19304733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefotetan: antibacterial activity against Staphylococcus aureus in the presence of human serum.
    Edwards JR
    Chemioterapia; 1988 Aug; 7(4):271-3. PubMed ID: 3180308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human albumin and serum on the in vitro bactericidal activity of cefditoren against penicillin-resistant Streptococcus pneumoniae.
    Sevillano D; Giménez MJ; Alou L; Aguilar L; Cafini F; Torrico M; González N; Echeverría O; Coronel P; Prieto J
    J Antimicrob Chemother; 2007 Jul; 60(1):156-8. PubMed ID: 17483149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
    Dorfman MS; Wagner RS; Jamison T; Bell B; Stroman DW
    Adv Ther; 2008 Mar; 25(3):208-17. PubMed ID: 18369536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of the displacement of protein binding by ibuprofen in the activity of a third-generation cephalosporin against Streptococcus pneumoniae].
    Cafini F; González N; Torrico M; Echeverría O; Sevillano D; Alou L; Giménez MJ; Aguilar L; Gómez-Lus ML
    Rev Esp Quimioter; 2006 Dec; 19(4):332-6. PubMed ID: 17235401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile delivery of amoxicillin against Streptococcus pneumoniae.
    Cha R; Rybak MJ
    J Antimicrob Chemother; 2004 Dec; 54(6):1067-71. PubMed ID: 15486084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a LC-MS quantification method for the lantibiotic MU1140 in rat plasma.
    Ghobrial OG; Derendorf H; Hillman JD
    J Pharm Biomed Anal; 2009 May; 49(4):970-5. PubMed ID: 19269770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae.
    Moisan H; Pruneau M; Malouin F
    J Antimicrob Chemother; 2010 Apr; 65(4):713-6. PubMed ID: 20097788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations.
    Schubert S; Dalhoff A; Stass H; Ullmann U
    Infection; 2005 Dec; 33 Suppl 2():15-21. PubMed ID: 16518707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of daptomycin, telavancin, teicoplanin, and vancomycin activity in the presence of albumin or serum.
    Tsuji BT; Leonard SN; Rhomberg PR; Jones RN; Rybak MJ
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):441-4. PubMed ID: 18248936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae].
    Andreoni O
    Minerva Med; 1983 Mar; 74(12):619-24. PubMed ID: 6339995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus.
    Leuthner KD; Cheung CM; Rybak MJ
    J Antimicrob Chemother; 2006 Aug; 58(2):338-43. PubMed ID: 16787952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.